Mirum Pharmaceuticals (MIRM) Net Equity Issued and Repurchased (2020 - 2023)

Mirum Pharmaceuticals' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $14.5 million for Q1 2023.

• In Q1 2023, Net Equity Issued and Repurchased changed N/A year-over-year to $14.5 million; the TTM figure through Dec 2023 stood at $14.5 million (changed N/A YoY), while the FY2023 annual figure was $14.5 million, down 31.98% from the prior year.
• Net Equity Issued and Repurchased for Q1 2023 stood at $14.5 million, down from $27.6 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $70.0 million in Q4 2020, with the low at $2.2 million in Q3 2020.
• The 3-year median for Net Equity Issued and Repurchased is $27.6 million (2022), against an average of $31.1 million.